Cargando…
Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome
Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) affects approximately 1% of the general population. It is a chronic, disabling, multi-system disease for which there is no effective treatment. This is probably related to the limited knowledge about its origin. Here, we summarized the c...
Autores principales: | Ruiz-Pablos, Manuel, Paiva, Bruno, Montero-Mateo, Rosario, Garcia, Nicolas, Zabaleta, Aintzane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634673/ https://www.ncbi.nlm.nih.gov/pubmed/34867935 http://dx.doi.org/10.3389/fimmu.2021.656797 |
Ejemplares similares
-
Epstein–Barr virus-acquired immunodeficiency in myalgic encephalomyelitis—Is it present in long COVID?
por: Ruiz-Pablos, Manuel, et al.
Publicado: (2023) -
Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome
por: Gravelsina, Sabine, et al.
Publicado: (2022) -
The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome
por: Hanson, Maureen R.
Publicado: (2023) -
Epstein-Barr Virus Induced Gene-2 Upregulation Identifies a Particular Subtype of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Kerr, Jonathan R.
Publicado: (2019) -
Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Blomberg, Jonas, et al.
Publicado: (2019)